Table 5 Medication use at baseline and year one for the ELMI and UC groups expressed as percent values (with absolute numbers).
Medication | ELMI (n = 151) | UC (n = 151) |
|---|---|---|
Lipid lowering | 87% (131) | 80% (121) |
β-Blocker | 70% (105) | 67% (101) |
ACE Inhibitor | 43% (65) | 41% (63) |
Calcium Channel Blocker | 26% (39) | 22% (33) |
Diuretic | 19% (28) | 15% (23) |
ASA | 89% (135) | 84% (127) |
Hypoglycemic Agents | 13% (19) | 17% (25) |
Angiotensin Receptor Blocker | 5% (7) | 3% (5) |
Anti-anginal | 19% (29) | 13% (20) |
Hormone Replacement Therapy (% women) | 19% (5) | 26% (7) |